BiotechTube
PeriGen

PeriGen

Princeton, United States· Est.
perigen.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17M

Overview

PeriGen is a private, revenue-generating company founded in 2008 that develops and commercializes AI/ML-driven software for obstetrics. Its flagship products, PeriWatch Surveillance and PeriWatch Vigilance, offer computerized fetal monitoring and a standalone maternal-fetal early warning system, aimed at reducing complications like NICU admissions and improving standardization of care. The company is led by clinicians and has secured FDA clearances for its software, with deployments across numerous US health systems. PeriGen operates in the high-growth digital health and AI in healthcare market, targeting the persistent need to improve outcomes in labor and delivery.

ObstetricsMaternal-Fetal Medicine

Technology Platform

PeriWatch platform: AI/ML-driven software suite for real-time maternal-fetal surveillance and automated early warning in labor & delivery. Incorporates patented algorithms for pattern recognition and statistical analysis of fetal heart rate, uterine activity, and maternal vital signs.

Funding History

2
Total raised:$17M
Series B$12M
Series A$5M

Opportunities

The urgent need to address the US maternal health crisis and reduce preventable complications creates a strong demand for safety-focused technologies.
The shift towards value-based care incentivizes hospitals to invest in tools proven to improve outcomes and reduce costs associated with NICU admissions and operative deliveries.
Expansion into international markets and integration with broader remote patient monitoring ecosystems present additional growth avenues.

Risk Factors

Competition from large, entrenched medical device and EMR vendors with broader product suites poses a challenge for market penetration and renewal.
Adoption depends on proving ROI through indirect reimbursement pathways and robust clinical outcomes data, which requires continuous investment.
The company must navigate complex hospital IT integration for each deployment and manage the medico-legal implications of AI-based clinical decision support.

Competitive Landscape

PeriGen competes in the perinatal software and fetal monitoring market against large medtech companies like GE Healthcare and Philips, which offer integrated hardware/software monitoring systems. It also faces competition from EHR giants (e.g., Epic, Oracle Cerner) that provide basic perinatal modules. Its key differentiation is its standalone, AI-powered early warning system (Vigilance) specifically designed for L&D, a niche where it currently claims a first-mover advantage.

More companies in Digital Health & Biotech SaaS →More companies in United States →